{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:35:16Z","timestamp":1760783716788},"reference-count":53,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:p>Cardiac hypertrophy in humans can progress to cardiac failure if the underlying impetus is poorly controlled. An important direct stimulator of hypertrophy and its progression is the angiotensin II (AngII) peptide. AngII also causes hypertension that indirectly contributes to cardiac hypertrophy. Others and we have shown that estrogens acting through the estrogen receptor (ER)-\u03b2 can inhibit AngII-induced or other forms of cardiac hypertrophy in mice. However, the proliferative effects of estrogen in breast and uterus that promote the development of malignancy preclude using the steroid to prevent cardiac disease progression. We therefore tested whether an ER\u03b2 selective agonist, \u03b2-LGND2, can prevent hypertension and cardiac pathology in female mice. AngII infusion over 3 weeks significantly stimulated systolic and diastolic hypertension, cardiac hypertrophy, and cardiac fibrosis, all significantly prevented by \u03b2-LGND2 in wild-type but not in ER\u03b2 genetically deleted mice. AngII stimulated the Akt kinase to phosphorylate and inhibit the glycogen synthase kinase-3\u03b2 kinase, leading to GATA4 transcription factor activation and hypertrophic mRNA expression. As a novel mechanism, all these actions were opposed by estradiol and \u03b2-LGND2. Our findings provide additional understanding of the antihypertrophic effects of ER\u03b2 and serve as an impetus to test specific receptor agonists in humans to prevent the worsening of cardiovascular disease.<\/jats:p>","DOI":"10.1210\/en.2013-1358","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T05:04:18Z","timestamp":1377234258000},"page":"4352-4364","source":"Crossref","is-referenced-by-count":29,"title":["ER\u03b2 Selective Agonist Inhibits Angiotensin-Induced Cardiovascular Pathology in Female Mice"],"prefix":"10.1210","volume":"154","author":[{"given":"Ali","family":"Pedram","sequence":"first","affiliation":[{"name":"Departments of Medicine (A.P., E.R.L.) University of California, Irvine, Irvine, California 92717"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Razandi","sequence":"first","affiliation":[{"name":"Division of Endocrinology (M.R., E.R.L.), Department of Veterans Affairs Medical Center, Long Beach, Long Beach, California 90822"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S.","family":"Korach","sequence":"first","affiliation":[{"name":"National Institute of Environmental Health Sciences (K.S.K.), Research Triangle Park, North Carolina 27709"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Narayanan","sequence":"first","affiliation":[{"name":"Division of Endocrinology (M.R., E.R.L.), Department of Veterans Affairs Medical Center, Long Beach, Long Beach, California 90822"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"Dalton","sequence":"first","affiliation":[{"name":"GTx Inc (J.T.D.), Memphis, Tennessee 38163"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis R.","family":"Levin","sequence":"first","affiliation":[{"name":"Division of Endocrinology (M.R., E.R.L.), Department of Veterans Affairs Medical Center, Long Beach, Long Beach, California 90822"},{"name":"Departments of Medicine (A.P., E.R.L.) University of California, Irvine, Irvine, California 92717"},{"name":"Departments of Biochemistry (E.R.L.), University of California, Irvine, Irvine, California 92717"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071612473835100_B1","doi-asserted-by":"crossref","first-page":"e013","DOI":"10.1621\/nrs.04013","article-title":"Estrogen signaling in the cardiovascular system","volume":"4","author":"Kim","year":"2006","journal-title":"Nucl Recept Signaling"},{"key":"2020071612473835100_B2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/416334a","article-title":"Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy","volume":"416","author":"Xin","year":"2002","journal-title":"Nature"},{"key":"2020071612473835100_B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"2020071612473835100_B4","doi-asserted-by":"crossref","first-page":"36981","DOI":"10.1074\/jbc.R300023200","article-title":"Control of cardiac growth and function by calcineurin signaling","volume":"278","author":"Vega","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B5","doi-asserted-by":"crossref","first-page":"26339","DOI":"10.1074\/jbc.M414409200","article-title":"Estrogen inhibits cardiomyocyte hypertrophy in vitro: antagonism of calcineurin-related hypertrophy through Induction of MCIP1","volume":"280","author":"Pedram","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B6","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/en.2008-0133","article-title":"Estrogen inhibits cardiac hypertrophy: role of estrogen receptor \u03b2 to inhibit calcineurin","volume":"149","author":"Pedram","year":"2008","journal-title":"Endocrinology"},{"key":"2020071612473835100_B7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Invest"},{"key":"2020071612473835100_B8","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1210\/me.2010-0154","article-title":"Estrogen receptor \u03b2 prevents cardiac fibrosis","volume":"24","author":"Pedram","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2020071612473835100_B9","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/hc4401.98414","article-title":"Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women","volume":"104","author":"Shlipak","year":"2001","journal-title":"Circulation"},{"key":"2020071612473835100_B10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0735-1097(03)00938-0","article-title":"Hormone replacement therapy is associated with improved survival in women with advanced heart failure","volume":"42","author":"Lindenfeld","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2020071612473835100_B11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0735-1097(00)00738-5","article-title":"Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the Vesnarinone studies","volume":"36","author":"Reis","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2020071612473835100_B12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00004872-200102000-00014","article-title":"Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women","volume":"19","author":"Light","year":"2001","journal-title":"J Hypertens"},{"key":"2020071612473835100_B13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrc1879","article-title":"Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis","volume":"6","author":"Shang","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2020071612473835100_B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.critrevonc.2003.09.003","article-title":"The biological role of estrogen receptors \u03b1 and \u03b2 in cancer","volume":"50","author":"Pearce","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"2020071612473835100_B15","doi-asserted-by":"crossref","first-page":"31292","DOI":"10.1074\/jbc.M110.147850","article-title":"Estrogen receptor \u03b2 selective ligands alleviate high-fat diet and ovariectomy-induced obesity in mice","volume":"285","author":"Yepuru","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B16","doi-asserted-by":"crossref","first-page":"15677","DOI":"10.1073\/pnas.95.26.15677","article-title":"Generation and reproductive phenotypes of mice lacking estrogen receptor \u03b2","volume":"95","author":"Krege","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612473835100_B17","first-page":"702","volume":"42","author":"Bergman","year":"1970","journal-title":"New spectrophotometric method for the determination of proline in tissue hydrolyzates"},{"key":"2020071612473835100_B18","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1210\/me.2008-0160","article-title":"Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways","volume":"22","author":"Narayanan","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2020071612473835100_B19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/282105a0","article-title":"Myosin isozymes redistribution in chronic heart overloading","volume":"282","author":"Lompre","year":"1979","journal-title":"Nature"},{"key":"2020071612473835100_B20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071612473835100_B21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.0305-1870.2004.04073.x","article-title":"Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review","volume":"31","author":"Woods","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071612473835100_B22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.RES.0000041029.97988.E9","article-title":"Ras\/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor antagonists in adult cardiomyocytes","volume":"91","author":"Wang","year":"2002","journal-title":"Circ Res"},{"key":"2020071612473835100_B23","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1073\/pnas.041614798","article-title":"Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo","volume":"98","author":"Rothermel","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612473835100_B24","doi-asserted-by":"crossref","first-page":"30401","DOI":"10.1074\/jbc.M200123200","article-title":"Multiple domains of MCIP1 contribute to inhibition of calcineurin activity","volume":"277","author":"Vega","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3\u03b2 suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc Nat Acad Sci USA"},{"key":"2020071612473835100_B26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"92","author":"Akazawa","year":"2003","journal-title":"Circ Res"},{"key":"2020071612473835100_B27","doi-asserted-by":"crossref","first-page":"28586","DOI":"10.1074\/jbc.M103166200","article-title":"Glycogen synthase kinase 3\u03b2 regulates GATA4 in cardiac myocytes","volume":"276","author":"Morisco","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B28","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1128\/MCB.19.6.4355","article-title":"Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression","volume":"19","author":"Charron","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2020071612473835100_B29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nm1552","article-title":"HDAC2 regulates the cardiac hypertrophic response by modulating GSK3\u03b2 activity","volume":"13","author":"Trivedi","year":"2007","journal-title":"Nat Med"},{"key":"2020071612473835100_B30","doi-asserted-by":"crossref","first-page":"22011","DOI":"10.1074\/jbc.M101579200","article-title":"Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase","volume":"276","author":"Minagawa","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.ATV.20.2.428","article-title":"In vivo evidence of the importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy","volume":"20","author":"Higaki","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071612473835100_B32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0895-7061(98)00251-9","article-title":"Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure","volume":"12","author":"Jacobi","year":"1999","journal-title":"Am J Hypertens"},{"key":"2020071612473835100_B33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","article-title":"Key advances in antihypertensive treatment","volume":"9","author":"Paulis","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"2020071612473835100_B34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.1065250","article-title":"Abnormal vascular function and hypertension in mice deficient in estrogen receptor \u03b2","volume":"295","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"2020071612473835100_B35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ Res"},{"key":"2020071612473835100_B36","first-page":"246058","article-title":"Chronic C-type natriuretic peptide infusion attenuates angiotensin II-induced myocardial superoxide production and cardiac remodeling","volume":"2012","author":"Izumiya","year":"2012","journal-title":"Int J Vasc Med"},{"key":"2020071612473835100_B37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","article-title":"Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system","volume":"88","author":"Gonz\u00e1lez","year":"2004","journal-title":"Med Clin North Am"},{"key":"2020071612473835100_B38","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.01087.2002","article-title":"Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction","volume":"284","author":"Cavasin","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612473835100_B39","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","article-title":"Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen","volume":"115","author":"Satoh","year":"2007","journal-title":"Circulation"},{"key":"2020071612473835100_B40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/cvr\/cvm081","article-title":"Ligand-dependent activation of ER lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized SHR","volume":"77","author":"Jazbutyte","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2020071612473835100_B41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/japplphysiol.01349.2011","article-title":"Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension","volume":"113","author":"Nadadur","year":"2012","journal-title":"J Appl Physiol"},{"key":"2020071612473835100_B42","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/CIRCULATIONAHA.112.126474","article-title":"The estrogen puzzle in pulmonary arterial hypertension","volume":"126","author":"Paulin","year":"2012","journal-title":"Circulation"},{"key":"2020071612473835100_B43","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0002-9149(99)00029-6","article-title":"Effect of hormone replacement therapy on left ventricular hypertrophy","volume":"83","author":"Lim","year":"1999","journal-title":"Am J Cardiol"},{"key":"2020071612473835100_B44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1291\/hypres.25.153","article-title":"Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women","volume":"25","author":"Miya","year":"2002","journal-title":"Hypertens Res"},{"key":"2020071612473835100_B45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1357-2725(98)00125-3","article-title":"Angiotensin II and extracellular matrix homeostasis","volume":"31","author":"Weber","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"2020071612473835100_B46","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000221824.87718.c0","article-title":"Smad3 mediates angiotensin II and TGF-\u03b21-induced vascular fibrosis: Smad3 thickens the plot","volume":"98","author":"Sorescu","year":"2006","journal-title":"Circ Res"},{"key":"2020071612473835100_B47","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.072647999","article-title":"Impaired cardiac hypertrophic response in calcineurin A\u03b2-deficient mice","volume":"99","author":"Bueno","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612473835100_B48","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1128\/MCB.22.21.7603-7613.2002","article-title":"Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth","volume":"22","author":"Wilkins","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2020071612473835100_B49","doi-asserted-by":"crossref","first-page":"H58","DOI":"10.1152\/ajpheart.2002.282.1.H58","article-title":"Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy","volume":"282","author":"Klinger","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612473835100_B50","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1097\/01.ASN.0000035087.11758.ED","article-title":"A mouse model of angiotensin II slow pressor response: role of oxidative stress","volume":"13","author":"Kawada","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2020071612473835100_B51","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.HYP.0000100445.80029.8E","article-title":"Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice","volume":"42","author":"Brede","year":"2003","journal-title":"Hypertension"},{"key":"2020071612473835100_B52","doi-asserted-by":"crossref","first-page":"19704","DOI":"10.1074\/jbc.M501244200","article-title":"Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors \u03b1 and \u03b2","volume":"280","author":"Guo","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071612473835100_B53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2310\/6650.2007.00020","article-title":"Intracardiac and intrarenal rennin-angiotensin systems: mechanism of cardiovascular and renal effects","volume":"55","author":"Raizada","year":"2007","journal-title":"J Investig Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/11\/4352\/13635785\/endo4352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/11\/4352\/13635785\/endo4352.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T21:54:50Z","timestamp":1594936490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/154\/11\/4352\/2423220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2013-1358","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}